Growth requirements and chromosomal instability of induced pluripotent stem cells generated from adult canine fibroblasts

Stem Cells and Development

Volumn 22, Issue 6, 2013, Pages 951-963

  Koh, Sehwon ^a   Thomas, Rachael ^a   Tsai, Shengdar ^a   Bischoff, Steve ^a   Lim, Ji Hey ^a   Breen, Matthew ^a   Olby, Natasha J ^a   Piedrahita, Jorge A ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; FIBROBLAST GROWTH FACTOR 2; LEUKEMIA INHIBITORY FACTOR;

ANEUPLOIDY; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL ISOLATION; CHROMOSOMAL INSTABILITY; CHROMOSOME ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; DOG; EMBRYONIC STEM CELL; FIBROBLAST; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DOSAGE; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOLID TUMOR; STEM CELL EXPANSION; STRUCTURE ANALYSIS; TERATOMA;

ALKALINE PHOSPHATASE; ANIMALS; ANTIGENS, DIFFERENTIATION; CELL DIFFERENTIATION; CELL SHAPE; CELLS, CULTURED; CHROMOSOMAL INSTABILITY; COCULTURE TECHNIQUES; COMPARATIVE GENOMIC HYBRIDIZATION; DOGS; FIBROBLASTS; GENE EXPRESSION; IN SITU HYBRIDIZATION, FLUORESCENCE; INDUCED PLURIPOTENT STEM CELLS; MICE; MICE, SCID; RECOMBINANT PROTEINS; TERATOMA; TRANSCRIPTION FACTORS;

MUS;

EID: 84876280276     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2012.0393     Document Type: Article

References (46)

1. Wu SM and K Hochedlinger. (2011). Harnessing the poten-tial of induced pluripotent stem cells for regenerative med-icine. Nat Cell Biol 13:497-505.
2. Hatoya S, R Torii, Y Kondo, T Okuno, K Kobayashi, V Wijewardana, N Kawate, H Tamada, T Sawada, et al. (2006). Isolation and characterization of embryonic stem-like cells from canine blastocysts. Mol Reprod Dev 73:298-305.
3. Schneider MR, H Adler, J Braun, B Kienzle, E Wolf and H Kolb. (2007). Canine embryo-derived stem cells\-toward clinically relevant animal models for evaluating efficacy and safety of cell therapies. Stem Cells 25:1850-1851.
4. Hayes B, SR Fagerlie, A Ramakrishnan, S Baran, M Harkey, L Graf, M Bar, A Bendoraite, M Tewari and B Torok-Storb. (2008). Derivation, characterization, and in vitro differentia-tion of canine embryonic stem cells. Stem Cells 26:465-473.
5. Vaags AK, S Rosic-Kablar, CJ Gartley, YZ Zheng, A Ches-ney, DA Villagomez, SA Kruth and MR Hough. (2009). Derivation and characterization of canine embryonic stem cell lines with in vitro and in vivo differentiation potential. Stem Cells 27:329-340.
6. Wilcox JT, E Semple, C Gartley, BA Brisson, SD Perrault, DA Villagomez, C Tayade, S Becker, R Lanza and DH Betts. (2009). Characterization of canine embryonic stem cell lines derived from different niche microenvironments. Stem Cells Dev 18:1167-1178.
7. Takahashi K and S Yamanaka. (2006). Induction of plurip-otent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676.
8. Okita K, T Ichisaka and S Yamanaka. (2007). Generation of germline-competent induced pluripotent stem cells. Nature 448:313-317.
9. Wernig M, A Meissner, R Foreman, T Brambrink, M Ku, K Hochedlinger, BE Bernstein and R Jaenisch. (2007). In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448:318-324.
10. Takahashi K, K Tanabe, M Ohnuki, M Narita, T Ichisaka, K Tomoda and S Yamanaka. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872.
11. Yu J, MA Vodyanik, K Smuga-Otto, J Antosiewicz-Bourget, JL Frane, S Tian, J Nie, GA Jonsdottir, V Ruotti, et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917-1920.
12. Liu H, F Zhu, J Yong, P Zhang, P Hou, H Li, W Jiang, J Cai, M Liu, et al. (2008). Generation of induced pluripotent stem cells from adult rhesus monkey fibroblasts. Cell Stem Cell 3:587-590.
13. Liao J, C Cui, S Chen, J Ren, J Chen, Y Ga, H Li, N Jia, L Cheng, H Xiao and L Xiao. (2009). Generation of induced pluripotent stem cell lines from adult rat cells. Cell Stem Cell 4:11-15.
14. Esteban MA, J Xu, J Yang, M Peng, D Qin, W Li, Z Jiang, J Chen, K Deng, et al. (2009). Generation of induced plurip-otent stem cell lines from Tibetan miniature pig. J Biol chem 284:17634-17640.
15. Ezashi T, BP Telugu, AP Alexenko, S Sachdev, S Sinha and RM Robers. (2009). Derivation of induced pluripotent stem cells from pig somatic cells. Proc Natl Acad Sci U S A 106:10993-10998.
16. Nagy K, HK Sung, P Zhang, S Laflamme, P Vincent, S Agha-Mohammadi, K Woltjen, C Monetti, IP Michael, LC Smith and A Nagy. (2011). Induced pluripotent stem cell lines derived from equine fibroblasts. Stem Cell Rev 7:693-702.
17. Shimada H, A Nakada, Y Hashimoto, K Shigeno, Y Shio-noya and T Nakamura. (2010). Generation of canine induced pluripotent stem cells by retroviral transduction and che-mical inhibitors. Mol Reprod Dev 77:2.
18. Luo J, ST Suhr, EA Chang, K Wang, PJ Ross, LL Nelson, PJ Venta, JG Knott and JB Cibelli. (2011). Generation of leuke-mia inhibitory factor and basic fibroblast growth factor-dependent induced pluripotent stem cells from canine adult somatic cells. Stem cells Dev 20:1669-1678.
19. Lee AS, D Xu, JR Plews, PK Nguyen, D Nag, JK Lyons, L Han, S Hu, F Lan, et al. (2011). Preclinical derivation and imaging of autologously transplanted canine induced plu-ripotent stem cells. J Biol Chem 286:32697-32704.
20. Whitworth DJ, DA Ovchinnikov and EJ Wolvetang. (2012). Generation and Characterization of LIF-dependent canine induced pluripotent stem cells from adult dermal fibro-blasts. Stem Cells Dev 21:2288-2297.
21. Ludwig T and JA Thomson. (2007). Defined, feeder-independent medium for human embryonic stem cell culture. Curr Protoc Stem Cell Biol Chapter 1:Unit 1C 2.
22. Takahashi K, K Okita, M Nakagawa and S Yamanaka. (2007). Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc 2:3081-3089.
23. Schmittgen TD and KJ Livak. (2008). Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3:1101-1108
24. Lindblad-Toh K, CM Wade, TS Mikkelsen, EK Karlsson, DB Jaffe, M Kamal, M Clamp, JL Chang, EJ Kulbokas, 3rd, et al. (2005). Genome sequence, comparative analysis and haplo-type structure of the domestic dog. Nature 438:803-819.
25. Nguyen HN and RA Reijo Pera. (2008). Metaphase spreads and spectral karyotyping of human embryonic stem cells. CSH Protoc pdb prot5047.
26. Miething F, S Hering, B Hanschke and J Dressler. (2006). Effect of fixation to the degradation of nuclear and mito-chondrial DNA in different tissues. J Histochem Cytochem 54:371-374.
27. Thomas R, SE Duke, EK Karlsson, A Evans, P Ellis, K Lindblad-Toh, CF Langford and M Breen. (2008). A genome assembly-integrated dog 1 Mb BAC microarray: a cytoge-netic resource for canine cancer studies and comparative genomic analysis. Cytogenet Genome Res 122:110-121.
28. GM Morrison, I Oikonomopoulou, RP Migueles, S Soneji, A Livigni, T Enver and JM Brickman. (2008). Anterior defini-tive endoderm from ESCs reveals a role for FGF signaling. Cell Stem Cell 3:402-415.
29. Doss MX, J Winkler, S Chen, R Hippler-Altenburg, I Sotir-iadou, M Halbach, K Pfannkuche, H Liang, H Schulz, et al. (2007). Global transcriptome analysis of murine embryonic stem cell-derived cardiomyocytes. Genome Biol 8:R56.
30. Zhang SC, M Wernig, ID Duncan, O Brustle and JA Thom-son. (2001). In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Bio-technol 19:1129-1133.
31. Nasonkin I, V Mahairaki, L Xu, G Hatfield, BJ Cummings, C Eberhart, DK Ryugo, D Maric, E Bar and VE Koliatsos. (2009). Long-term, stable differentiation of human embry-onic stem cell-derived neural precursors grafted into the adult mammalian neostriatum. Stem Cells 27:2414-2426.
32. Shi Y, C Desponts, JT Do, HS Hahm, HR Scholer and S Ding. (2008). Induction of pluripotent stem cells from mouse em-bryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 3:568-574.
33. Greber B, G Wu, C Bernemann, JY Joo, DW Han, K Ko, N Tapia, D Sabour, J Sterneckert, P Tesar and HR Scholer. (2010). Conserved and divergent roles of FGF signaling in mouse epiblast stem cells and human embryonic stem cells. Cell Stem Cell 6:215-226.
34. Baker DE, NJ Harrison, E Maltby, K Smith, HD Moore, PJ Shaw, PR Heath, H Holden and PW Andrews. (2007). Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nat Biotechnol 25:207-215.
35. Lefort N, M Feyeux, C Bas, O Feraud, A Bennaceur-Griscelli, G Tachdjian, M Peschanski and AL Perrier. (2008). Human embryonic stem cells reveal recurrent genomic instability at 20q11.21. Nat Biotechnol 26:1364-1366.
36. Spits C, I Mateizel, M Geens, A Mertzanidou, C Staessen, Y Vandeskelde, J Van der Elst, I Liebaers and K Sermon. (2008). Recurrent chromosomal abnormalities in human embryonic stem cells. Nat Biotechnol 26:1361-1363.
37. Mayshar Y, U Ben-David, N Lavon, JC Biancotti, B Yakir, AT Clark, K Plath, WE Lowry and N Benvenisty. (2011). Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 7:521-531.
38. Lister R, M Pelizzola, YS Kida, RD Hawkins, JR Nery, G Hon, J Antosiewicz-Bourget, R O'Malley, R Castanon, et al. (2011). Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 471:68-73.
39. Laurent LC, I Ulitsky, I Slavin, H Tran, A Schork, R Morey, C Lynch, JV Harness, S Lee, et al. (2011). Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and i PSCs during reprogramming and time in culture. Cell Stem Cell 8:106-118.
40. Hussein SM, NN Batada, S Vuoristo, RW Ching, R Autio, E Narva, S Ng, M Sourour, R Hamalainen, et al. (2011). Copy number variation and selection during reprogramming to pluripotency. Nature 471:58-62.
41. Angstadt AY, A Motsinger-Reif, R Thomas, WC Kisseberth, C Guillermo Couto, DL Duval, DM Nielsen, JF Modiano and M Breen. (2011). Characterization of canine osteosarcoma by array comparative genomic hybridization and RT-q PCR signatures of genomic imbalance in canine osteosarcoma parallel the human counterpart. Genes Chromosomes Can-cer 50:859-874.
42. Hedan B, R Thomas, A Motsinger-Reif, J Abadie, C Andre, J Cullen and M Breen. (2012). Molecular cytogenetic charac-terization of canine histiocytic sarcoma: a spontaneous model for human histiocytic cancer identifies deletion of tumor suppressor genes and highlights influence of genetic background on tumor behavior. BMC Cancer 11:201.
43. Thomas R, SE Duke, HJ Wang, TE Breen, RJ Higgins, KE Linder, P Ellis, CF Langford, PJ Dickinson, NJ Olby and M Breen. (2009). 'Putting our heads together': insights into genomic conservation between human and canine intracra-nial tumors. J Neurooncol 94:333-349.
44. Thomas R, EL Seiser, A Motsinger-Reif, L Borst, VE Valli, K Kelley, SE Suter, D Argyle, K Burgess, et al. (2011). Refining tumor-associated aneuploidy through 'genomic recoding' of recurrent DNA copy number aberrations in 150 canine non-Hodgkin lymphomas. Leuk Lymphoma 52:1321-1335.
45. Ben-David U and N Benvenisty. (2012). High prevalence of evolutionarily conserved and species-specific genomic aberrations in mouse pluripotent stem cells. Stem Cells 30:612-622.
46. Breen M. (2008). Canine cytogenetics\-from band to base-pair. Cytogenet Genome Res 120:50-60.